EDESA BIOTECH, INC. Financing Cash Flow
EDESA BIOTECH, INC. (EDSA) reported Financing Cash Flow of $6.79 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- EDESA BIOTECH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $3.45M.
- EDESA BIOTECH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$8.98K, a 100.06% decline year-over-year.
- EDESA BIOTECH, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.36M, a 61.98% increase year-over-year.
- EDESA BIOTECH, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $186.48K.
- EDESA BIOTECH, INC. net cash provided by (used in) financing activities for fiscal 2025 was $17.03M, a 2776.69% increase from fiscal 2024.
- EDESA BIOTECH, INC. net cash provided by (used in) financing activities for fiscal 2024 was $592.03K, a 87.74% decline from fiscal 2023.
- EDESA BIOTECH, INC. net cash provided by (used in) financing activities for fiscal 2023 was $4.83M, a 58.47% decline from fiscal 2022.
- EDESA BIOTECH, INC. net cash provided by (used in) financing activities for fiscal 2022 was $11.63M, a 17.96% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | $3.44M derived: sum of 2 quarters · filed 2026-08-13 | $6.79M 10-Q · filed 2026-08-13 | $6.98M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$8.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | $3.35M 10-Q · filed 2026-05-14 | $3.53M derived: sum of 3 quarters · filed 2026-05-14 | $3.53M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.36M 10-Q · filed 2026-02-13 | $3.54M derived: sum of 2 quarters · filed 2026-02-13 | $3.54M derived: sum of 3 quarters · filed 2026-08-13 | $18.31M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $186.48K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $186.48K derived: sum of 2 quarters · filed 2026-08-13 | $14.96M derived: sum of 3 quarters · filed 2026-08-13 | $17.03M 10-K · filed 2025-12-12 |
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | $14.77M derived: sum of 2 quarters · filed 2026-08-13 | $16.84M 10-Q · filed 2026-08-13 | $16.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $14.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | $16.84M 10-Q · filed 2026-05-14 | $16.81M derived: sum of 3 quarters · filed 2026-05-14 | $16.92M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $2.07M 10-Q · filed 2026-02-13 | $2.04M derived: sum of 2 quarters · filed 2026-02-13 | $2.15M derived: sum of 3 quarters · filed 2026-02-13 | $2.36M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-09-30 | -$31.43K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | $74.59K derived: sum of 2 quarters · filed 2025-12-12 | $286.29K derived: sum of 3 quarters · filed 2025-12-12 | $592.03K 10-K · filed 2025-12-12 |
| 2024-06-30 | $106.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $317.72K derived: sum of 2 quarters · filed 2025-08-08 | $623.47K 10-Q · filed 2025-08-08 | $1.04M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $211.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $517.44K 10-Q · filed 2025-05-14 | $929.91K derived: sum of 3 quarters · filed 2025-05-14 | $1.67M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $305.74K 10-Q · filed 2025-02-14 | $718.21K derived: sum of 2 quarters · filed 2025-02-14 | $1.46M derived: sum of 3 quarters · filed 2025-02-14 | $2.22M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $412.46K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13 | $1.15M derived: sum of 2 quarters · filed 2024-12-13 | $1.92M derived: sum of 3 quarters · filed 2024-12-13 | $4.83M 10-K · filed 2024-12-13 |
| 2023-06-30 | $741.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $1.51M derived: sum of 2 quarters · filed 2024-08-09 | $4.42M 10-Q · filed 2024-08-09 | $4.42M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $764.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-10 | $3.68M 10-Q · filed 2024-05-10 | $3.68M derived: sum of 3 quarters · filed 2024-05-10 | $3.68M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $2.91M 10-Q · filed 2024-02-09 | $2.91M derived: sum of 2 quarters · filed 2024-02-09 | $2.91M derived: sum of 3 quarters · filed 2024-02-09 | $13.31M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-09-30 | -$286.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | -$286.00 derived: sum of 2 quarters · filed 2023-12-15 | $10.40M derived: sum of 3 quarters · filed 2023-12-15 | $11.63M 10-K · filed 2023-12-15 |
| 2022-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | $10.40M derived: sum of 2 quarters · filed 2023-08-09 | $11.63M 10-Q · filed 2023-08-09 | $11.85M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $10.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | $11.63M 10-Q · filed 2023-05-11 | $11.85M derived: sum of 3 quarters · filed 2023-05-11 | $11.87M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.23M 10-Q · filed 2023-02-10 | $1.45M derived: sum of 2 quarters · filed 2023-02-10 | $1.47M derived: sum of 3 quarters · filed 2023-02-10 | $13.41M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-09-30 | $221.04K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | $236.94K derived: sum of 2 quarters · filed 2022-12-16 | $12.18M derived: sum of 3 quarters · filed 2022-12-16 | $14.17M 10-K · filed 2022-12-16 |
| 2021-06-30 | $15.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | $11.96M derived: sum of 2 quarters · filed 2022-08-12 | $13.95M 10-Q · filed 2022-08-12 | $17.18M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $11.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $13.94M 10-Q · filed 2022-05-13 | $17.17M derived: sum of 3 quarters · filed 2022-05-13 | $17.14M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $1.99M 10-Q · filed 2022-02-14 | $5.22M derived: sum of 2 quarters · filed 2022-02-14 | $5.20M derived: sum of 3 quarters · filed 2022-02-14 | $9.04M derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | $3.20M derived: sum of 2 quarters · filed 2021-12-28 | $7.05M derived: sum of 3 quarters · filed 2021-12-28 | $7.09M 10-K · filed 2021-12-28 |
| 2020-06-30 | -$27.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $3.82M derived: sum of 2 quarters · filed 2021-08-13 | $3.86M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | $3.89M 10-Q · filed 2021-05-14 | ||
| 2019-12-31 | $45.00K 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | $0.00 10-K · filed 2020-12-07 | |||
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-12 | $0.00 derived: sum of 2 quarters · filed 2020-08-12 | $0.00 10-Q · filed 2020-08-12 | $0.00 derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | $0.00 10-Q · filed 2020-05-15 | $0.00 derived: sum of 3 quarters · filed 2020-05-15 | |
| 2018-12-31 | $0.00 10-Q · filed 2020-02-13 | $0.00 derived: sum of 2 quarters · filed 2020-02-13 | ||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $8.77M 10-K · filed 2018-11-30 | ||
| 2018-06-30 | $8.77M 10-Q · filed 2018-08-08 | |||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $0.00 10-K · filed 2018-11-30 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-08 | |||
| 2016-09-30 | $7.31M 10-K · filed 2017-12-01 | |||
| 2015-09-30 | $106.78K 10-K · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |